Lithium Investing Frontier Lithium PEA Demonstrates Attractive 27% IRR Pre-Tax for Lithium Chemical Production in North America’s Great Lakes Region
Radiopharm Theranostics Doses First Patient with 18F-RAD101 in U.S. Phase 2b Imaging Study of Brain MetastasisÂ
SOURCE ROCK ROYALTIES ANNOUNCES FOURTH QUARTER & YEAR-END 2024 RESULTS INCLUDING RECORD ANNUAL FUNDS FROM OPERATIONS
